V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016344 | 270009017 | 1.7 | 64 | Curative (C) | 2016-09-13 | 2016-09-13 | BEAM | N | N | 270014883 | BEAM |
| 270016345 | 270009020 | 1.61 | 66.9 | Palliative (P) | 2015-01-07 | 2015-01-23 | Cetuximab + FOLFIRI cycle1 | N | N | 270014884 | CETUXIMAB + IRINOTECAN + MDG |
| 270016346 | 270009020 | 1.69 | 60.3 | Curative (C) | 2016-04-14 | 2016-04-15 | OEPA | N | null | 270014884 | OEPA |
| 270016347 | 270009023 | 1.32 | 85.8 | Disease modification (D) | 2015-09-09 | 2016-10-01 | Mini BEAM | N | N | 270014886 | BEAM |
| 270016348 | 270009032 | 1.8 | 79.8 | Curative (C) | 2018-03-31 | 2018-03-31 | BEAM | 2 | N | 270014892 | BEAM |
| 270016349 | 270009034 | 1.59 | 84.45 | Curative (C) | 2016-03-26 | 2016-04-07 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 270014893 | CISPLATIN + RT |
| 270016350 | 270009036 | 1.82 | 77.9 | Disease modification (D) | 2016-02-16 | 2016-02-16 | Cisplatin + Radiotherapy | 02 | N | 270014899 | CISPLATIN + RT |
| 270016351 | 270009036 | 1.83 | 89.6 | Curative (C) | 2015-11-24 | 2015-12-06 | HD EuroNet-PHL-C1 OEPA | N | N | 270014899 | OEPA |
| 270016352 | 270009039 | null | 129.8 | null | 2013-08-16 | 2013-08-18 | OEPA | null | null | 270014907 | OEPA |
| 270016353 | 270018295 | 1.8 | 72 | Curative (C) | 2017-03-12 | 2017-03-20 | ESHAP | N | Y | 270014910 | ESHAP |
| 270016354 | 270014236 | 1.62 | 92 | Curative (C) | 2018-03-29 | 2018-04-01 | BEAM | N | N | 270014914 | BEAM |
| 270016355 | 270009044 | 1.73 | null | Curative (C) | 2018-07-15 | 2018-09-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | 270014927 | CETUXIMAB + IRINOTECAN + MDG |
| 270016356 | 270009047 | 1.77 | 77 | Disease modification (D) | 2017-10-23 | 2017-10-23 | LEAM | N | N | 270014931 | LEAM |
| 270016357 | 270009051 | 1.84 | 67.6 | Palliative (P) | 2015-01-24 | 2015-09-20 | Cetuximab + FLUOROURACIL + IRINOTECAN | N | N | 270014941 | CETUXIMAB + IRINOTECAN + MDG |
| 270016358 | 270014239 | 1.62 | 57 | Curative (C) | 2018-02-04 | 2018-02-08 | BMT BEAM | N | N | 270014945 | BEAM |
| 270016359 | 270009055 | 1.73 | null | Curative (C) | 2013-10-17 | 2015-03-03 | ESHAP | N | N | 270014950 | ESHAP |
| 270016360 | 270009058 | 1.56 | 55.4 | Neo-adjuvant (N) | 2015-03-29 | 2016-04-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270014957 | CETUXIMAB + IRINOTECAN + MDG |
| 270016361 | 270009060 | 1.72 | 109.3 | Adjuvant (A) | 2013-02-17 | 2013-03-21 | LEAM | 2 | N | 270014958 | LEAM |
| 270016362 | 270016812 | 1.57 | 68 | Curative (C) | 2018-04-04 | 2018-04-09 | ESHAP | 2 | N | 270014959 | ESHAP |
| 270016363 | 270014243 | 1.43 | 53.2 | Curative (C) | 2017-10-14 | 2017-12-22 | BEAM | N | Y | 270014960 | BEAM |
| 270016364 | 270014243 | 1.78 | 128 | Adjuvant (A) | 2017-06-10 | 2017-06-11 | Rituximab | N | N | 270014960 | RITUXIMAB |
| 270016365 | 270009070 | 1.77 | 118 | Curative (C) | 2017-05-21 | 2017-05-28 | BEAM | N | N | 270014963 | BEAM |
| 270016366 | 270009071 | 1.72 | 59 | Curative (C) | 2016-02-10 | 2016-03-02 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014964 | CETUXIMAB + IRINOTECAN + MDG |
| 270016367 | 270009072 | 1.48 | 56 | Curative (C) | null | 2016-01-10 | ESHAP | N | null | 270014973 | ESHAP |
| 270016368 | 270009073 | 1.82 | 84 | null | 2014-08-21 | 2014-08-23 | LEAM | N | N | 270014974 | LEAM |
| 270016369 | 270009077 | 1.8 | 65.5 | Curative (C) | 2017-06-11 | 2017-06-11 | OEPA | N | N | 270014979 | OEPA |
| 270016370 | 270009082 | 1.75 | 98.999 | Palliative (P) | 2013-09-26 | 2013-10-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270014984 | CETUXIMAB + IRINOTECAN + MDG |
| 270016371 | 270014252 | null | 43 | Adjuvant (A) | 2016-08-03 | 2016-08-03 | OEPA | N | N | 270014985 | OEPA |
| 270016372 | 270009087 | null | 69.4 | Curative (C) | 2017-12-31 | 2018-02-12 | LEAM | N | N | 270014987 | LEAM |
| 270016373 | 270009087 | 1.74 | 89.3 | Curative (C) | 2017-04-16 | 2017-04-16 | BEAM | N | N | 270014987 | BEAM |
| 270016374 | 270009089 | 1.72 | 83.6 | Curative (C) | 2017-02-15 | 2017-02-15 | Rituximab (Maintenance) | N | N | 270014999 | RITUXIMAB |
| 270016375 | 270009094 | 1.88 | 75.4 | Curative (C) | 2016-08-28 | 2016-08-29 | LEAM | 02 | N | 270015000 | LEAM |
| 270016376 | 270014256 | 1.5 | 66 | Curative (C) | 2016-09-12 | 2016-09-13 | BEAM | 02 | Y | 270015003 | BEAM |
| 270016377 | 270009097 | 1.73 | 63 | Palliative (P) | 2015-08-05 | 2015-08-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 270015004 | CETUXIMAB + IRINOTECAN + MDG |
| 270016378 | 270009099 | 0.98 | 58.2 | Adjuvant (A) | 2015-10-27 | 2015-10-28 | OEPA | 02 | N | 270015007 | OEPA |
| 270016379 | 270009101 | 1.5 | 92.9 | Curative (C) | 2015-03-09 | 2015-04-23 | LEAM | 2 | N | 270015011 | LEAM |
| 270016380 | 270009104 | 1.64 | 87.35 | null | 2015-07-17 | 2015-07-19 | Rituximab | N | N | 270015016 | RITUXIMAB |
| 270016381 | 270009107 | 1.66 | 97 | Curative (C) | 2017-10-05 | 2017-10-05 | Rituximab | 02 | null | 270015020 | RITUXIMAB |
| 270016382 | 270009111 | 1.8 | 56.8 | Palliative (P) | 2013-07-22 | 2013-07-28 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270015034 | CETUXIMAB + IRINOTECAN + MDG |
| 270016383 | 270009111 | 1.75 | 120 | Curative (C) | 2018-08-09 | 2018-08-09 | BEAM | N | N | 270015034 | BEAM |
| 270016384 | 270009111 | 1.8 | 84.8 | Curative (C) | 2017-05-03 | 2017-05-04 | Rituximab | N | N | 270015034 | RITUXIMAB |
| 270016385 | 270009112 | null | 87.5 | Palliative (P) | 2013-11-12 | 2013-11-20 | Mini BEAM | 2 | N | 270015043 | BEAM |
| 270016386 | 270009114 | 0 | 51.5 | Curative (C) | 2017-11-24 | 2017-11-25 | Rituximab | 02 | N | 270015048 | RITUXIMAB |
| 270016387 | 270009119 | 1.76 | 101.9 | Curative (C) | 2018-04-16 | 2018-04-16 | Cisplatin 100 + RT(H&N) 1 day | null | null | 270015054 | CISPLATIN + RT |
| 270016388 | 270016828 | 1.56 | 73.45 | null | 2014-09-10 | 2014-09-29 | Cisplatin + Radiotherapy | N | N | 270015062 | CISPLATIN + RT |
| 270016389 | 270009123 | 1.7 | 29 | Curative (C) | 2015-05-21 | 2015-05-21 | ESHAP | N | null | 270015063 | ESHAP |
| 270016390 | 270016829 | 1.7 | null | Curative (C) | null | 2015-07-11 | CISPLATIN + RT | N | N | 270015065 | CISPLATIN + RT |
| 270016391 | 270009127 | 1.72 | 53.3 | null | 2014-08-04 | 2014-08-07 | BEAM | N | Y | 270015075 | BEAM |
| 270016392 | 270014272 | 1.61 | 56 | Palliative (P) | 2015-12-29 | 2015-12-29 | Cetuximab + FLUOROURACIL + IRINOTECAN | N | N | 270015077 | CETUXIMAB + IRINOTECAN + MDG |
| 270016393 | 270014273 | null | null | Curative (C) | 2014-08-07 | 2014-08-07 | Rituximab | N | N | 270015083 | RITUXIMAB |